Vertex Pharmaceuticals's total assets for Q1 2026 were $26.48B, an increase of 1.31% from the previous quarter. VRTX total liabilities were $7.12B for the fiscal quarter, a -4.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.